Nano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, 110067, India.
Guru Gobind Singh Indraprastha University, Golf Course Rd, Sector 16 C, Dwarka, 110078, India.
Talanta. 2022 Jun 1;243:123376. doi: 10.1016/j.talanta.2022.123376. Epub 2022 Mar 19.
SP17 is a mammalian protein found in the testis and spermatozoa that have been identified as a tumor-associated antigen in a range of human cancers. A unique method for fabricating the first ultrasensitive, selective, and label-free immunosensor for the detection of SP17, a new cancer biomarker in complicated serum samples, is presented in this paper. This immunosensor was also the first biosensor built using a disposable ITO sheet modified with an aminosilane known as APTMS as an immobilization platform for fabricating the SP17 biosensor. The immobilization of chemical and biological species onto the electrode surface was cross-verified by various analytical and morphological techniques. Stepwise modifications done on the immunoelectrodes were also studied using electrochemical techniques. Selective interaction between anti-SP17 and SP17 with varying concentrations (100-5000 pg mL) was measured with the DPV technique. The immunosensor exhibited low LOD and LOQ of 70.07 and 233.57 pg mL, respectively, with a sensitivity of 0.013 μA mL pg cm. The fabricated immunosensor performance was analyzed by quantifying the SP17 concentrations in patient serum samples. The data obtained from the developed immunosensor demonstrated excellent reproducibility, repeatability, and selectivity among various interferants, including cancer biomarkers. Further, the observed results have been validated via ELISA, which showed good agreement with the electrochemical results. This could establish a new platform for detecting other cancer biomarkers and can be employed for clinical diagnostics applications.
SP17 是一种在哺乳动物睾丸和精子中发现的蛋白质,已被鉴定为多种人类癌症中的肿瘤相关抗原。本文提出了一种用于检测 SP17 的超灵敏、选择性和无标记免疫传感器的独特方法,SP17 是一种新的癌症生物标志物,存在于复杂的血清样本中。该免疫传感器也是第一个使用经 APTMS 修饰的一次性 ITO 片作为固定化平台来构建 SP17 生物传感器的生物传感器。通过各种分析和形态技术交叉验证了化学和生物物质在电极表面上的固定。还使用电化学技术研究了免疫电极上的逐步修饰。使用 DPV 技术测量了抗 SP17 与具有不同浓度(100-5000 pg mL)的 SP17 之间的选择性相互作用。该免疫传感器的 LOD 和 LOQ 分别为 70.07 和 233.57 pg mL,灵敏度为 0.013 μA mL pg cm。通过定量分析患者血清样本中的 SP17 浓度来分析所制备的免疫传感器的性能。通过 ELISA 验证了所开发的免疫传感器的结果,显示出与电化学结果的良好一致性。这可以为检测其他癌症生物标志物建立一个新的平台,并可用于临床诊断应用。